Cbdmd Share Price (NYSE: YCBD)

$0.65

▲

0.02

(3.17%)

Live

Last updated on August 20, 2025 at 11:20 PM IST

$₹

Check the interactive Cbdmd Stock chart to analyse performance

Cbdmd stock performance

as on August 20, 2025 at 11:20 PM IST

Today's Low:$0.60
Today's High:$0.70
$0.65
7.69%
Downside
Day's Volatility :14.29%
Upside
7.14%
52 Weeks Low:$0.59
52 Weeks High:$6.54
$0.65
8.77%
Downside
52 Weeks Volatility :90.93%
Upside
90.06%

Cbdmd Stock Returns

Period	Cbdmd Inc	Index (Russel 2000)
3 Months	-32.58%	0.0%
6 Months	-82.19%	0.0%
1 Year	-85.95%	0.0%
3 Years	-99.62%	-9.6%

Cbdmd Inc Key Stats

Check Cbdmd key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$0.63
Open	$0.67
Today's High	$0.7
Today's Low	$0.6
Market Capitalization	$6.1M
Today's Volume	$106.5K
52 Week High	$6.5384
52 Week Low	$0.593
Revenue TTM	$19.0M
EBITDA	$-641.5K
Earnings Per Share (EPS)	$86.16
PE Ratio	0.01
Profit Margin	-7.96%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-33.13%

Stock Returns calculator for Cbdmd Stock including INR - Dollar returns

The Cbdmd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cbdmd investment value today

Current value as on today

₹18,797

Returns

₹81,203

(-81.2%)

Returns from Cbdmd Stock

₹85,092 (-85.09%)

Dollar Returns*

₹3,889 (+3.89%)

Indian investors sentiment towards Cbdmd Stock

11%

Period: Jul 20, 2025 to Aug 19, 2025. Change in 30 Days versus previous period

Search interest for Cbdmd Stock from India on INDmoney has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Cbdmd Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Cbdmd(by analysts ranked 0 to 5 stars)

Cbdmd Share Price Target

What analysts predicted

Upside of 361.54%

Target:

$3.00

Current:

$0.65

Cbdmd share price target is $3.00, a slight Upside of 361.54% compared to current price of $0.65 as per analysts' prediction.

Cbdmd Stock Insights

Price Movement
In the last 7 days, YCBD stock has moved down by -32.7%
Decreasing Revenue
Revenue is down for the last 3 quarters, 5.11M → 4.60M (in $), with an average decrease of 5.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -1.48M → -895.27K (in $), with an average increase of 65.5% per quarter
YCBD vs HLN (1 yr)
In the last 1 year, Cbdmd Inc has experienced a drawdown of -86.0%, however Haleon Plc Spon Ads resisted the overall trend and outperformed by 85.0%
YCBD vs HLN (3 yr)
In the last 3 years, Haleon Plc Spon Ads has given 63.0% return, outperforming this stock by 162.6%
Price to Sales
ForYCBD every $1 of sales, investors are willing to pay $0.1, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Cbdmd Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$23.7M	↑ 180.89%
Net Income	$-45.4M	↑ 10924.64%
Net Profit Margin	-192.08%	↓ 187.19%

	FY20	Y/Y Change
Revenue	$41.9M	↑ 77.09%
Net Income	$12.6M	↓ 127.74%
Net Profit Margin	30.09%	↑ 222.17%

	FY21	Y/Y Change
Revenue	$44.5M	↑ 6.2%
Net Income	$-23.4M	↓ 285.64%
Net Profit Margin	-52.6%	↓ 82.69%

	FY22	Y/Y Change
Revenue	$35.4M	↓ 20.41%
Net Income	$-74.1M	↑ 216.67%
Net Profit Margin	-209.26%	↓ 156.66%

	FY23	Y/Y Change
Revenue	$24.2M	↓ 31.77%
Net Income	$-22.9M	↓ 69.04%
Net Profit Margin	-94.96%	↑ 114.3%

	FY24	Y/Y Change
Revenue	$19.5M	↓ 19.35%
Net Income	$-3.7M	↓ 83.87%
Net Profit Margin	-18.99%	↑ 75.97%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$4.4M	↓ 18.58%
Net Income	$-3.0M	↑ 202.11%
Net Profit Margin	-68.79%	↓ 50.25%

	Q2 FY24	Q/Q Change
Revenue	$5.2M	↑ 18.22%
Net Income	$459.7K	↓ 115.27%
Net Profit Margin	8.89%	↑ 77.68%

	Q3 FY24	Q/Q Change
Revenue	$4.6M	↓ 11.94%
Net Income	$-152.8K	↓ 133.24%
Net Profit Margin	-3.35%	↓ 12.24%

	Q4 FY24	Q/Q Change
Revenue	$5.1M	↑ 12.23%
Net Income	$15.1K	↓ 109.88%
Net Profit Margin	0.3%	↑ 3.65%

	Q1 FY25	Q/Q Change
Revenue	$4.7M	↓ 7.12%
Net Income	$-1.5M	↓ 9912.9%
Net Profit Margin	-31.19%	↓ 31.49%

	Q2 FY25	Q/Q Change
Revenue	$4.6M	↓ 3.0%
Net Income	$-895.3K	↓ 39.56%
Net Profit Margin	-19.43%	↑ 11.76%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$14.5M	↑ 152.57%

	FY20	Y/Y Change
Profit	$26.4M	↑ 81.67%

	FY21	Y/Y Change
Profit	$30.0M	↑ 13.72%

	FY22	Y/Y Change
Profit	$22.3M	↓ 25.51%

	FY23	Y/Y Change
Profit	$15.0M	↓ 32.95%

	FY24	Y/Y Change
Profit	$12.0M	↓ 19.91%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$2.6M	↓ 21.17%

	Q2 FY24	Q/Q Change
Profit	$3.4M	↑ 31.88%

	Q3 FY24	Q/Q Change
Profit	$2.5M	↓ 27.9%

	Q4 FY24	Q/Q Change
Profit	$3.4M	↑ 38.59%

	Q1 FY25	Q/Q Change
Profit	$3.0M	↓ 12.98%

	Q2 FY25	Q/Q Change
Profit	$2.8M	↓ 4.33%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-15.4M	↑ 175.92%
Investing Cash Flow	$-2.1M	↑ 212.17%
Financing Cash Flow	$17.9M	↑ 74.73%

	FY20	Y/Y Change
Operating Cash Flow	$-10.7M	↓ 30.65%
Investing Cash Flow	$-1.6M	↓ 26.42%
Financing Cash Flow	$22.4M	↑ 24.84%

	FY21	Y/Y Change
Operating Cash Flow	$-14.1M	↑ 32.15%
Investing Cash Flow	$-2.6M	↑ 62.54%
Financing Cash Flow	$28.2M	↑ 26.21%

	FY22	Y/Y Change
Operating Cash Flow	$-15.0M	↑ 6.2%
Investing Cash Flow	$-688.7K	↓ 73.01%
Financing Cash Flow	$-4.0M	↓ 114.29%

	FY23	Y/Y Change
Operating Cash Flow	$-4.3M	↓ 71.26%
Investing Cash Flow	$702.5K	↓ 202.0%
Financing Cash Flow	$-1.3M	↓ 67.22%

	FY24	Y/Y Change
Operating Cash Flow	$-352.8K	↓ 91.8%
Investing Cash Flow	$-290.0K	↓ 141.29%
Financing Cash Flow	$1.3M	↓ 198.09%

Q1 FY24

Q4 FY24

Q1 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-704.1K	↑ 526.48%
Investing Cash Flow	$4.6K	↓ 102.5%
Financing Cash Flow	$1.3M	↓ 52079.21%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-317.9K	↓ 289.96%
Investing Cash Flow	$-164.4K	-
Financing Cash Flow	$1.0	↑ 0.0%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-507.1M	↑ 159393.52%
Investing Cash Flow	$-179.7M	↑ 109232.62%
Financing Cash Flow	$0.0	↓ 100.0%

Cbdmd Technicals Summary

Sell

Neutral

Buy

Cbdmd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cbdmd Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cbdmd Inc	-34.84%	-82.19%	-85.95%	-99.62%	-99.94%
Haleon Plc Spon Ads	2.31%	-2.3%	-1.02%	56.75%	31.58%
United Therapeutics Corporation	6.99%	-17.64%	-9.59%	42.35%	76.36%
Zoetis Inc.	5.63%	-0.62%	-15.21%	-5.68%	-1.7%
Neurocrine Biosciences Inc.	0.78%	16.28%	-11.18%	25.09%	17.46%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cbdmd Inc	0.01	0.01	NA	-4.08	-0.33	-0.09	NA	0.69
Haleon Plc Spon Ads	21.51	21.51	3.09	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	12.22	12.22	1.43	26.61	0.19	0.13	NA	158.65
Zoetis Inc.	26.84	26.84	2.47	6.32	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	39.29	39.29	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cbdmd Inc	Buy	$6.1M	-99.94%	0.01	-7.96%
Haleon Plc Spon Ads	Buy	$43.4B	31.58%	21.51	13.81%
United Therapeutics Corporation	Buy	$14.2B	76.36%	12.22	40.36%
Zoetis Inc.	Buy	$69.0B	-1.7%	26.84	27.83%
Neurocrine Biosciences Inc.	Buy	$13.2B	17.46%	39.29	13.88%

About Cbdmd Inc

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.

Organization	Cbdmd
Employees	42
CEO	Mr. T. Ronan Kennedy
Industry	Other Consumer Services

Key Management of Cbdmd Inc

Name	Title
Mr. T. Ronan Kennedy	Interim CEO, CFO, Principal Executive Officer & Director
Mr. Bradley Whitford	Chief Accounting Officer, Treasurer & Secretary
Dr. Sibyl Swift Ph.D.	CSO, VP of Regulatory Affairs & Director
Zeb Booker	Chief Technology Officer
Mr. Lance Blundell	General Counsel
Robert Pettway	Director of Public Relations
Mr. Francisco Mangual	Senior VP of Sales
Ms. Shannon Charles	Chief Marketing Officer
Mr. David Johnson	Senior VP of Business Development

Important FAQs about investing in YCBD Stock from India :

What is Cbdmd share price today?

Cbdmd share price today is $0.65 as on August 20, 2025 at 11:20 PM IST. Cbdmd share today touched a day high of $0.70 and a low of $0.60.

What is the 52 week high and 52 week low for Cbdmd share?

Cbdmd share touched a 52 week high of $6.54 and a 52 week low of $0.59. Cbdmd stock price today i.e. August 20, 2025 at 11:20 PM IST is trending at $0.65, lower by 90.06% versus the 52 week high.

How to invest in Cbdmd Stock (YCBD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cbdmd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cbdmd Shares that will get you 2.3077 shares as per Cbdmd share price of $0.65 per share as on August 20, 2025 at 11:20 PM IST.

What is the minimum amount required to buy Cbdmd Stock (YCBD) from India?

Indian investors can start investing in Cbdmd (YCBD) shares with as little as ₹87.0225 or $1 (as of August 20, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹870.22 in Cbdmd stock (as per the Rupee-Dollar exchange rate as on August 20, 2025). Based on Cbdmd share’s latest price of $0.65 as on August 20, 2025 at 11:20 PM IST, you will get 15.3846 shares of Cbdmd. Learn more about fractional shares .

What are the returns that Cbdmd has given to Indian investors in the last 5 years?

Cbdmd stock has given -99.94% share price returns and 16.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?